PTK6 enhances EGFR signaling by inhibiting EGFR down-regulation (Kang et al. 2010, Li et al. 2012, Kang and Lee 2013). PTK6 may also enhance signaling by other receptor tyrosine kinases (RTKs), such as IGF1R (Fan et al. 2013) and ERBB3 (Kamalati et al. 2000).
PTK6 affects AKT1 activation (Zhang et al. 2005, Zheng et al. 2010) and targets negative regulator of RTKs, DOK1, for degradation (Miah et al. 2014).
Zheng, Y, Peng, M, Wang, Z, Asara, JM, Tyner, AL
Zhang, P, Ostrander, JH, Faivre, EJ, Olsen, A, Fitzsimmons, D, Lange, CA
Kang, SA, Lee, ES, Yoon, HY, Randazzo, PA, Lee, ST
Miah, S, Goel, RK, Dai, C, Kalra, N, Beaton-Brown, E, Bagu, ET, Bonham, K, Lukong, KE
Kang, SA, Lee, ST
Kamalati, T, Jolin, HE, Fry, MJ, Crompton, MR
Fan, G, Lin, G, Lucito, R, Tonks, NK
Li, X, Lu, Y, Liang, K, Hsu, JM, Albarracin, C, Mills, GB, Hung, MC, Fan, Z
© 2021 Reactome